NE NEWS SERVICE
AHMEDABAD, DECEMBER 5
Stating that cardiovascular diseases contributed 28·1% of the total deaths in India in 2016 and around 36% of deaths in adult population above 40 years of age are due to heart diseases in Gujarat, to reduce the mortality and morbidity due to heart disease and its risk factors in India by 2025. Madhavbaug has made a definite headway in curbing all the lifestyle diseases and has been promoting its unique treatment methodology consisting of a combination of lifestyle adjustments, correct diet and Ayurvedic treatments, besides its patented procedure, Sampurna Hriday Shuddhikaran, said Dr. Suhas Dawkhar, Patient engagement Officer, Madhavbaug here on Thursday.
To overcome the fear of heart disease, Madhavbaug is holding “Hrudayrog Vijayotsav Sankalpana” at Gujarat University Senate Hall, Ahmedabad on December 10 and MS University, Vadodara on December 11, respectively.
Talking to reporters after a panel discussion at Ahmedabad Management Association, Ahmedabad, Dr Suhas Dawkhar said 40-50 patients who won against the heart disease will be honoured at these events.
Dr. Suhas Dawkhar, Patient engagement Officer, Madhavbaug said, “Madhavbaug is the world’s first Ayurvedic cardiac care provider and has the only patented non-invasive Ayurvedic procedure for cardiac treatment — Sampurna Hriday Shuddhikaran, a six-day residential therapy. Sane Care group managing director Dr. Rohit Sane has developed this patented therapy SHS, an amalgam of Ayurveda and modern systems of medicine, for cardiac diseases. Further, heart disease, diabetes, blood pressure and obesity are completely reversible now if one undergoes SHS.”
Dr. Sadik Khan, Regional Medical Head –Madhavbaug, Gujarat said, “The Ayurveda market currently stands at Rs 30,000 crore. With a vision of reducing the Heart disease burden in India, accessibility, affordability and availability have been the hallmarks of Madhavbaug services.”
Madhavbaug has successfully treated more than one lakh heart patients so far. It has successfully felicitated more than 2,000 diabetes reversed patients in such Vijayotsav events till now. Only 2 per cent of the patients have failed to follow the doctor’s advise leading to recurrence of diabetes, Dr Dr. Suhas Dawkhar revealed.
R&D is Madhavbaug’s forte
Madhavbaug’s research on heart diseases, diabetes and hypertension has been published in reputed medical journals at national and international level, like the Indian Heart Journal, Lancet and the British Journal of Medicine and Medical Research, as well as medical conferences like the International Conference on Clinical and Experimental Cardiology.
